← FDA Drug Approvals (Drugs@FDA)

BIVALIRUDIN IN 0.9% SODIUM CHLORIDE

NDA · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2017-12-21

Drug application

FDA Application #

NDA208374

Application type

New Drug Application

Brand name

BIVALIRUDIN IN 0.9% SODIUM CHLORIDE

Generic name

Bivalirudin

Active ingredients

BIVALIRUDIN

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

BAXTER HLTHCARE CORP

First approval

2017-12-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown